Effects of Remodulin in Patients With Critical Limb Ischemia Following a Vein Bypass Graft

Summary

Approximately 30 patients will be enrolled in this 12-week study designed to assess the effect of continuous subcutaneous Remodulin therapy on the outcome of infrainguinal bypass grafts in patients with critical limb ischemia (CLI). Portions of the study will be conducted in the hospital and on an out-patient basis. The study will be conducted at multiple centers.

Timeline

Start

2003-03

Primary completion

2003-12

Completion

2003-12

Drugs

Indications